Alzheimer's Disease Preclinical Efficacy Database (AlzPED)
AlzPED is a publicly available, searchable, data resource that aims to increase the transparency, reproducibility and translatability of preclinical efficacy studies of candidate therapeutics for Alzheimer’s disease. AlzPED is designed as a knowledge platform for the dissemination of data and analysis to scientists, from academic centers, industry, disease-focused foundations, in a manner that promotes efficiency, transparency, reproducibility and accuracy of research aimed at preclinical therapy development for AD. AlzPED provides quick access and visibility to integrated preclinical efficacy data from published and unpublished studies. Visit the AlzPED website.